For: | Lemaire CC, Portilho ALC, Pinheiro LV, Vivas RA, Britto M, Montenegro M, Rodrigues LFF, Arruda S, Lyra AC, Cavalcante LN. Sweet syndrome as a paraneoplastic manifestation of cholangiocarcinoma: A case report. World J Clin Cases 2020; 8(18): 4122-4127 [PMID: 33024770 DOI: 10.12998/wjcc.v8.i18.4122] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v8/i18/4122.htm |
Number | Citing Articles |
1 |
Mihai-Lucian Ciobica, Bianca-Andreea Sandulescu, Liana-Maria Chicea, Mihaela Iordache, Maria-Laura Groseanu, Mara Carsote, Claudiu Nistor, Ana-Maria Radu. The Constellation of Risk Factors and Paraneoplastic Syndromes in Cholangiocarcinoma: Integrating the Endocrine Panel Amid Tumour-Related Biology (A Narrative Review). Biology 2024; 13(9): 662 doi: 10.3390/biology13090662
|
2 |
Tejas P. Joshi, Sarah K. Friske, David A. Hsiou, Madeleine Duvic. New Practical Aspects of Sweet Syndrome. American Journal of Clinical Dermatology 2022; 23(3): 301 doi: 10.1007/s40257-022-00673-4
|
3 |
Richard E. Kast, Alex Alfieri, Hazem I. Assi, Terry C. Burns, Ashraf M. Elyamany, Maria Gonzalez-Cao, Georg Karpel-Massler, Christine Marosi, Michael E. Salacz, Iacopo Sardi, Pieter Van Vlierberghe, Mohamed S. Zaghloul, Marc-Eric Halatsch. MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen. Cancers 2022; 14(10): 2563 doi: 10.3390/cancers14102563
|